Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Chemical suppression of an oncogenic splicing variant of AIMP2 induces tumour regression.

Lee HS, Kim DG, Oh YS, Kwon NH, Lee JY, Kim D, Park SH, Song JH, Lee S, Han JM, Park BJ, Lee J, Kim S.

Biochem J. 2013 Sep 15;454(3):411-6. doi: 10.1042/BJ20130550.

PMID:
23815603
2.

Selective regression of cancer cells expressing a splicing variant of AIMP2 through targeted RNA replacement by trans-splicing ribozyme.

Won YS, Lee SW.

J Biotechnol. 2012 Mar 31;158(1-2):44-9. doi: 10.1016/j.jbiotec.2012.01.006. Epub 2012 Jan 21.

PMID:
22285955
3.

Lentiviral vector-mediated shRNA against AIMP2-DX2 suppresses lung cancer cell growth through blocking glucose uptake.

Chang SH, Chung YS, Hwang SK, Kwon JT, Minai-Tehrani A, Kim S, Park SB, Kim YS, Cho MH.

Mol Cells. 2012 Jun;33(6):553-62. doi: 10.1007/s10059-012-2269-2. Epub 2012 May 4.

4.

Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis.

Choi JW, Kim DG, Lee AE, Kim HR, Lee JY, Kwon NH, Shin YK, Hwang SK, Chang SH, Cho MH, Choi YL, Kim J, Oh SH, Kim B, Kim SY, Jeon HS, Park JY, Kang HP, Park BJ, Han JM, Kim S.

PLoS Genet. 2011 Mar;7(3):e1001351. doi: 10.1371/journal.pgen.1001351. Epub 2011 Mar 31.

5.

Ratio of Autoantibodies of Tumor Suppressor AIMP2 and Its Oncogenic Variant Is Associated with Clinical Outcome in Lung Cancer.

Jung JY, Kim EY, Kim A, Chang J, Kwon NH, Moon Y, Kang EJ, Sung JS, Shim H, Kim S, Chang YS.

J Cancer. 2017 May 12;8(8):1347-1354. doi: 10.7150/jca.18450. eCollection 2017.

6.

Rapid detection of exon 2-deleted AIMP2 mutation as a potential biomarker for lung cancer by molecular beacons.

Jo SM, Kim Y, Jeong YS, Hee Oh Y, Park K, Kim HS.

Biosens Bioelectron. 2013 Aug 15;46:142-9. doi: 10.1016/j.bios.2013.02.037. Epub 2013 Mar 6.

PMID:
23537880
7.

Purification and biophysical characterization of the AIMP2-DX2 protein.

Jha R, Cho HY, Mushtaq AU, Lee K, Kim DG, Kim S, Jeon YH.

Protein Expr Purif. 2017 Apr;132:131-137. doi: 10.1016/j.pep.2017.02.002. Epub 2017 Feb 7.

PMID:
28185908
8.

Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer.

Choi JW, Lee JW, Kim JK, Jeon HK, Choi JJ, Kim DG, Kim BG, Nam DH, Kim HJ, Yun SH, Kim S.

J Mol Cell Biol. 2012 Jun;4(3):164-73. doi: 10.1093/jmcb/mjs018. Epub 2012 Apr 24.

PMID:
22532625
9.

Inhibiting DX2-p14/ARF Interaction Exerts Antitumor Effects in Lung Cancer and Delays Tumor Progression.

Oh AY, Jung YS, Kim J, Lee JH, Cho JH, Chun HY, Park S, Park H, Lim S, Ha NC, Park JS, Park CS, Song GY, Park BJ.

Cancer Res. 2016 Aug 15;76(16):4791-804. doi: 10.1158/0008-5472.CAN-15-1025. Epub 2016 Jun 14.

10.

Data on optimization of expression and purification of AIMP2-DX2 protein in Escherichia coli.

Jha R, Cho HY, Mushtaq AU, Lee K, Kim DG, Kim S, Jeon YH.

Data Brief. 2017 Mar 10;11:533-536. doi: 10.1016/j.dib.2017.03.011. eCollection 2017 Apr.

11.

Oncogenic Mutation of AIMP2/p38 Inhibits Its Tumor-Suppressive Interaction with Smurf2.

Kim DG, Lee JY, Lee JH, Cho HY, Kang BS, Jang SY, Kim MH, Guo M, Han JM, Kim SJ, Kim S.

Cancer Res. 2016 Jun 1;76(11):3422-36. doi: 10.1158/0008-5472.CAN-15-3255. Epub 2016 Apr 6.

12.

Multidirectional tumor-suppressive activity of AIMP2/p38 and the enhanced susceptibility of AIMP2 heterozygous mice to carcinogenesis.

Choi JW, Um JY, Kundu JK, Surh YJ, Kim S.

Carcinogenesis. 2009 Sep;30(9):1638-44. doi: 10.1093/carcin/bgp170. Epub 2009 Jul 21.

PMID:
19622630
13.

COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells.

Ramer R, Heinemann K, Merkord J, Rohde H, Salamon A, Linnebacher M, Hinz B.

Mol Cancer Ther. 2013 Jan;12(1):69-82. doi: 10.1158/1535-7163.MCT-12-0335. Epub 2012 Dec 7.

14.

A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancer.

Tang YA, Wen WL, Chang JW, Wei TT, Tan YH, Salunke S, Chen CT, Chen CS, Wang YC.

PLoS One. 2010 Sep 14;5(9):e12417. doi: 10.1371/journal.pone.0012417.

15.

[Tumor growth inhibition of paclitaxel-octreotide conjugates on human non small cell lung cancer: experiment with mice].

Shen HC, Wang XW, Liu YG.

Zhonghua Yi Xue Za Zhi. 2008 Sep 16;88(35):2498-503. Chinese.

PMID:
19080633
16.

[Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].

Zhou YL, Hu WX, Lü YP, Qiu LN, Wang WS, Yang ZY, Liu JD, Rao GW.

Yao Xue Xue Bao. 2007 Jan;42(1):26-34. Chinese.

PMID:
17520803
17.

Lentivirus-AIMP2-DX2 shRNA suppresses cell proliferation by regulating Akt1 signaling pathway in the lungs of AIMP2⁺/⁻ mice.

Hwang SK, Chang SH, Minai-Tehrani A, Kim YS, Cho MH.

J Aerosol Med Pulm Drug Deliv. 2013 Jun;26(3):165-73. doi: 10.1089/jamp.2011.0959. Epub 2013 Mar 21.

PMID:
23517169
18.

Orphan receptor TR3 participates in cisplatin-induced apoptosis via Chk2 phosphorylation to repress intestinal tumorigenesis.

Yao LM, He JP, Chen HZ, Wang Y, Wang WJ, Wu R, Yu CD, Wu Q.

Carcinogenesis. 2012 Feb;33(2):301-11. doi: 10.1093/carcin/bgr287. Epub 2011 Dec 9.

PMID:
22159226
19.

Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.

Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel Doeberitz M, Debatin KM.

Cancer Res. 2003 Jun 15;63(12):3112-20.

20.

Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.

Liu Q, Zhao XY, Bai RZ, Liang SF, Nie CL, Yuan Z, Wang CT, Wu Y, Chen LJ, Wei YQ.

Oncol Rep. 2009 Nov;22(5):1069-75.

PMID:
19787223

Supplemental Content

Support Center